RUA — Rua Life Sciences Balance Sheet
0.000.00%
Last trade - 00:00- £7.21m
- £4.73m
- £2.19m
- 21
- 51
- 77
- 46
Annual balance sheet for Rua Life Sciences, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 1.98 | 6.29 | 2.96 | 1.48 | 3.93 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.078 | 0.277 | 0.504 | 0.209 | 0.721 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 2.23 | 7.33 | 4.21 | 2.15 | 4.99 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.005 | 1.95 | 2.6 | 2.74 | 2.46 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Total Assets | 2.49 | 10.2 | 7.63 | 5.66 | 8.17 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.219 | 1.1 | 0.511 | 0.414 | 0.554 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.219 | 1.65 | 1.04 | 0.98 | 0.987 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 2.27 | 8.51 | 6.58 | 4.68 | 7.18 |
| Total Liabilities & Shareholders' Equity | 2.49 | 10.2 | 7.63 | 5.66 | 8.17 |
| Total Common Shares Outstanding |